chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Nausea; Headaches; This is a spontaneous report from a contactable consumer, the patient.  A 73-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 15Mar2021 at 11:00 (Batch/Lot Number: EN6207) as 1st dose, single dose for covid-19 immunization. The patient did not had any medical history. Prior to the vaccination she was not diagnosed with COVID 19. Since the vaccination, she had not been tested for COVID-19. The patient did not had allergies to medications, food, or other products. The patient does not receive any other vaccines within 4 weeks prior to the COVID vaccine neither had any other medications within 2 weeks of vaccination. The facility where the most recent COVID-19 vaccine was administered was reported to be other not specified. On an unknown date, the patient experienced dizziness so severe that she could not stand up and also experienced headaches and nausea. Second day in still have dizziness. Therapeutic measures were taken included, that patient visited the emergency department and meclizine was prescribed by the emergency room doctor. At the time of the report, the outcome of the events dizziness, headache and nausea was not resolved.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Reporter's last name added,Patient's first name added in patient tab,Patient's age/units added in patient tab,State was update from full name to two capital digital state in patient tab,AE onset date/time was updated,Emergency room visit was checked,Treatment received was ticked as Yes and Relevant med history was added as None.
patient had  post vaccine reaction to the Janssen vaccine.  he lost consciousness without warning, his upper extremities were fixed and postured towards his chest.  He contracted.  He was LOC for an estimate of 15 seconds duration.  He reported feeling nothing preluding to the LOC.  He was fearful and agitated upon arousal.  EMS alerted and patient workup done by EMS.  Unknown whether patient refuses or consented to Hospital Observation.
DEVELOPED FATIGUE, WEAKNESS. NORMALLY AMBULATES WITH A WALKER, BUT REQUIRED A 2-ASSIST WITH TRANSFER AND USING A WHEEL CHAIR. WAITING FOR GUIDANCE FROM PCP.
Initial information received on 13-Sep-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves two adult patients who experienced feeling ill, fever, nausea and body ache, while he/she received vaccine FLUZONE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE lot UI995AA. On an unknown date, the patient developed a non-serious feeling ill (malaise) within 24 hours following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. On an unknown date, the patient developed a non-serious fever (pyrexia) within 24 hours following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. On an unknown date, the patient developed a non-serious nausea within 24 hours following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. On an unknown date ¸the patient developed a non-serious body ache (pain) within 24 hours following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. No lab data reported. Final diagnosis was body ache, nausea, fever and feeling ill. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for all the events.
It expired on 08Jun2023 (30th day)/(6 doses of Moderna Covid-19 bivalent were Administered.); No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (It expired on 08Jun2023 (30th day)/(6 doses of Moderna Covid-19 bivalent were Administered.)) and NO ADVERSE EVENT (No adverse event) in a 74-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7184B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (It expired on 08Jun2023 (30th day)/(6 doses of Moderna Covid-19 bivalent were Administered.)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (It expired on 08Jun2023 (30th day)/(6 doses of Moderna Covid-19 bivalent were Administered.)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (It expired on 08Jun2023 (30th day)/(6 doses of Moderna Covid-19 bivalent were Administered.)).    This case contains information for the 1st of 6 patients described by the reporter.  No concomitant medication was reported.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-729006, US-MODERNATX, INC.-MOD-2023-729007, US-MODERNATX, INC.-MOD-2023-729012, US-MODERNATX, INC.-MOD-2023-729016, US-MODERNATX, INC.-MOD-2023-729015 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-729006:(Patient no- 2 out of 6 ) US-MODERNATX, INC.-MOD-2023-729007:(Patient no- 3 out of 6 ) US-MODERNATX, INC.-MOD-2023-729012:(Patient no- 4 out of 6 ) US-MODERNATX, INC.-MOD-2023-729016:(Patient no- 6 out of 6 ) US-MODERNATX, INC.-MOD-2023-729015:(Patient no- 5 out of 6 )
FAINTING AFTER RECEIVING DOSE OF PFIZER OCCURRED IMMEDIATELY AFTER ADMINSTRATION, PATIENT PASSED OUT IN CHAIR. THEN WAS MOVED TO THE FLOOR IN A PRONE POSITION WITH LEGS ELEVATED FOR 5-10 MIN.  THEN MOVED TO SITTING POSITION WHERE HE PASSED OUT AGAIN.  WE MOVED HIM BACK TO PRONE POSITION WHEN THE PARAMEDICS ARRIVED WE MOVED HIM TO A CHAIR WHERE HE PASSED OUT FOR A THIRD TIME.  PATIENT DID REPORT SEVERE ANXIETY WITH VACCINATIONS AND HAPPENED TO PASS OUT WITH THE FIRST SHOT BUT DID NOT REPORT THIS TO THE PHARMACIST ADMINISTERING OR ON THE CONSENT FORM.
This spontaneous report was received from a pharmacist and refers to a 82-year-old female patient. The patient's concomitant therapies included some unspecified medications. The patient did not have any pertinent medical history, drug reactions or allergies. On 07-NOV-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 intramuscularly in right arm, lot# N020502 and expiration date 08-FEB-2019 (dose was not reported) as pneumonia prevention. On approximately 08-NOV-2017 (reported as "about a day later"), the patient started having redness, stiffness and swelling on her right arm. It was reported that the swelling was about the size of a grapefruit. No treatment was given for the events and no lab diagnostics were performed. The patient did not seek medical attention. The outcome of the events was reported as not recovered. The relatedness between the events and PNEUMOVAX 23 was not reported.
I could not keep my eyes open. I was extremely drowsy; really sick; chills; fever; body aches; diarrhea; nausea; migraine; This is a spontaneous report from a contactable consumer (patient). A 21-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, in left arm, on 25Feb2021 13:15 (at the age of 21-years-old), at dose 1, single for covid-19 immunization. The patient had no medical history or known allergies. Concomitant medications included norethindrone (NORETHISTERONE) taken for birth control and fluoxetine. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient has not been tested with covid-19 after the vaccination. On 06Mar2021 23:30, immediately after returning home (as reported) the patient could not keep eyes open; she was extremely drowsy. It was also reported that, a little over a week after receiving the vaccine (as reported), she got sick, and experienced chills, fever, body aches, diarrhea, nausea, migraine (06Mar2021 23:30). No treatment was administered for the events. The outcome of the events was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
15 days after receiving FLUVAX got dx Bells Palsy. No prodromal virus infections, No other Imms, No h/o HSV.
rash on arms, legs, hands, feet that itches, burns and is painful.  Patient had 2 visits to Urgent Care- 3/4/21 & 3/6/21, PCP OV 3/8/21- Medrol dose pack, Decadron IM, Triamcinolone Cream, Betamethasone Cream
Moderna vaccine was administered outside of source; reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------ DX code - I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 8/15/2021 BILAT CAROTID ARTERY STENOSIS
Fever; Chills; I feel very tired; I can hardly walk; Sore throat; I have a cold; The (most serious) issue is my throat, I feel like I have something (stuck) in my throat; I feel like I can't breathe normally; I can't speak; I do not feel well/I feel terrible/I feel isolated; I have pain in my body; I could hardly stand up/I did not got to work; Feel an itch, like an allergy, it was not a rash, just an urge to scratch me; Feeling dizzy; Nauseous; Headache; This is a spontaneous report from a contactable consumer (patient). A 46-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 01Feb2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported that she received the COVID-19 vaccine at a hospital, patients were allowed to stay for 30 minutes, then they were released. After she left the hospital she started to feel an itch, like an allergy, it was not a rash, just an urge to scratch herself. She started feeling dizzy, nauseous, and a headache. Yesterday (02Feb2021), she could hardly stand up. Today (03Feb2021) she did not got to work, she do not feel well, she have pain in her body, fever and chills. The (most serious) issue was her throat, she feel like she have something (stuck) in her throat, she can't speak, she feel like she can't breathe normally. She haven't felt well at all, today is the 3rd day after receiving the vaccine and she couldn't go to work, she was nervous because she was fine (before receiving the vaccine). She does not want to go out because she feel very tired and dizzy, she was afraid of falling down in the street and getting hurt, she can hardly walk and she feel tired, experienced fatigue and sore throat. She have a cold, she feel terrible. she feel isolated and afraid. She will have to go to the hospital, if she cannot breathe well. Outcome of the events was unknown.   Information about Lot/batch no has been requested.
rosy cheeks every once in a while; some itchiness on her head; experience pain like someone is pressing knuckles into her head; Patient started to notice hair loss; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (Patient started to notice hair loss), ROSACEA (rosy cheeks every once in a while), PRURITUS (some itchiness on her head) and HEADACHE (experience pain like someone is pressing knuckles into her head) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, D37B21A and 048A21A) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2022, the patient experienced ALOPECIA (Patient started to notice hair loss), PRURITUS (some itchiness on her head) and HEADACHE (experience pain like someone is pressing knuckles into her head). On an unknown date, the patient experienced ROSACEA (rosy cheeks every once in a while). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, ALOPECIA (Patient started to notice hair loss), PRURITUS (some itchiness on her head) and HEADACHE (experience pain like someone is pressing knuckles into her head) had not resolved and ROSACEA (rosy cheeks every once in a while) outcome was unknown.            No concomitant medications were reported.   On an unspecified date in January the patient started to notice hair loss. She also continued to experience pain like someone was pressing knuckles into her head and some itchiness on her head. This was continued, off and on, up until the day of this report. The patient also had rosy cheeks every once in a while. The patient visited 2 internists and 2 dermatologists for her symptoms and was treated with topical steroids for 2 weeks and ibuprofen or aspirin a couple of times.
On January 5, female patient 21 y/o, came in to the office under a procedure encounter to received vaccines as prescribed by provider. She received Hepatitis B, Varicella and MMR. Vaccine administration without adverse effects or complications observed. However, when documenting medical assistant noticed that the Hep B vaccine administration wasn't for adults, patient received the Hep B for adolescent or pediatric (0-19 y/o). Next day the situation was notified to me, and manager and medical director were informed about. Doctor (Medical Director has been trying to contact the patient without success to be notify her to come back. Request sent by MD to Care Coordinator to send a letter to the patient requesting a call back
Dizziness and nausea within 2 mins of the vaccine. Dizziness went away after 10 mins but nausea has remained for over 24hours.
Patient woke up with soreness in arm.  Injection site was warm to touch and hard.  Had a raised rash surrounding site of about 3 inch radius.  Patient texted a picture of her arm to one of our techs who is related to her.  Patient said she was applying ice and had taken Benadryl.  I told her to continue to watch the area and I would call later in day to check on her which I did. When I called her this afternoon she was on her way to her doctor and was complaining of having trouble breathing.
First dose on 4/27/21.  The day following first dose, pt developed chest pain (dull/tightness, 3/10).  Worsened after the second dose on 5/18/21.
Muscle aches in lower back. Nausea, fever and lymph nodes swelling under arm.
Paralysis on my left side of face.  I got my vaccine on Thursday 1/14/21. On Friday 1/15/21 evening started have numbing of left side of my face.
because of worsening shortness of breath for last 24 hours.  The patient had recent diagnosis of atrial fibrillation with RVR.  She was tested positive for COVID- 19 in January 2022.  The patient reported poor appetite lately, intermittent dry cough, but no fever, no chills.  In the ER, her O2 saturation was 100% on 2 L nasal cannula.  Chest x-ray showed worsening left-sided pleural effusion. The patient was admitted for further evaluation. atelectasis, small pleural effusion.   She has recent COVID-19 infection 1/19/22 Repeated covid test  2/5 is still positive   Procalcitonin 0.1. She was discharged on 02/07/22 in stable condition.
Patient and patient's father returned to clinic approximately three hours after Varicella vaccine administrered (administered 05/05/09). Patient had developed mild, full body rash after receiving Varicella shot (second varicella vaccine-no reaction reported to first vaccine). Patient  appeared well with the exception of the rash (patient complained of mild pruritis but otherwise no other complaints reported). Patient's father denied any previous allergic reaction to medication, vaccinations or food. Telephone call made by this nurse to Dr.; verbal order given for liquid Benadryl based on body weight. Patient's father instructed to follow dosing instructions on Benadryl label based upon pt's body weight of 60 lbs. Patient's father left clinic and then returned the next day reporting that he was concerned and had taken the patient to the emergency room last night and was told that the patient was "fine." Made telephone call to patient's father on 05/11/09 and informed by patient's father that the rash "went away" and patient is well.
Deep muscle pain @ injection site, progressively getting worse after injection. Pain radiates to shoulder trapezius muscle and neck. 3 wks post injection still painful decrease use decrease strength. Given MEDROL dose pack w/ minimal relief. On light duty.
Pt left store without incident. Shortly Pt felt pain in left leg then pain in back. In evening Pt went to ER and was admitted - six days in hosp was trx to rehab.
Sore arm; chills; tiredness; swollen lymph node; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA COVID-19 VACCINE; Lot number: EN6206), via an unspecified route of administration in her left arm on 18Mar2021 at 17:00 hours (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included Obstructive Sleep Apnea (OSA), pre-diabetic, obesity, non-alcoholic fatty liver disease and gastroparesis. No concomitant medications were not reported within two weeks of vaccination. The patient had previously received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA COVID-19 VACCINE; Lot number: EN6202), via an unspecified route of administration in her left arm on 25Feb2021 at 17:00 hours, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and the patient has not tested positive for COVID-19 since receiving the vaccine. On 18Mar2021, the patient experienced sore arm, chills, tiredness, and swollen lymph node. No therapeutic measures were taken as a result of the events experienced. The clinical outcome of the events sore arm, chills, tiredness and swollen lymph node was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a physician via company representative refers to a female patient of unknown age. The patient medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with GARDASIL first dose ("one single shot") (dose, frequency, route, lot number and expiration date were not provided) for the prevention of HPV. No concomitant therapies were reported. On an unknown date, the patient developed terrible pain at the injection site within 44 hours after receiving the 1st shot of GARDASL. The patient was in a such pain that she woke up in the middle of the night screaming and her mother had to help her. The patient woke up the following morning and was able to do cross country running and {Tae Kwon Do}. The mother of the patient wanted to GARDASIL vaccine washed out of the patients system and did not want her to get the 2nd and 3rd shots of GARDASIL. Vaccination with next doses of GARDASIL was discontinued. The outcome of terrible pain at the injection site was reported as recovered/resolved (date unspecified). The relatedness between the event and the therapy with GARDASIL was unknown. The patient did not seek medical attention. Additional information has been requested.
Muscle soreness in the left deltoid that began almost immediately after receiving vaccination on 03Apr2021, pained worsened in through the following day, resolving ~72hours after administration.  At ~72 hours after vaccination also noticed splotchy redness on the same arm as administration, but under the deltoid muscle, the redness was accompanied by minor bruising.  Currently ongoing 06Apr2021.  Took 1000mg of Acetaminophen at ~6 hours post-dose, one time only.
Patient became dizzy and fainted within minutes of vaccine administration. BP 80/44, HR: 48. Patient vital signs monitored for half hour at 5 min interval. Head of.
SEVERE HEADACHE AND BODY AND JOINT PAIN, SKIN HURTS, SORE THROAT, LOW GRADE FEVER-100F, LOCALIZED REACTION INITIALLY-REDNESS & SWELLING.
Narrative:  COVID infections following completion of COVID vaccine series 02/11/21 COVID vaccine dose #1 03/04/21 COVID vaccine dose #2 03/26/21 Pt presents to clinic reporting pain and swelling in ankles and foot since Saturday (03/20); suspected to be gout related - labs and xray ordered; advised to d/c NSAIDs and rx given for medrol dose pack 04/22/21 Pt presents to clinic reporting stomach pain that was recently evaluated in the ER; discharged from ER with antibiotics and dicyclomine; rx given for omeprazole and H. pylori antigen test and Barium exam ordered 07/22/21 Pt reports exposure to COVID positive wife; COVID NEGATIVE 07/26/21 Pt reports body aches and mild headache and exposure to COVID positive co-worker; COVID POSITIVE 07/27/21 Pt reports body aches, nasal congestion, fatigue 07/29/21 Pt reports chills, cough, fever, headache, muscle pain, runny nose, sore throat; rx given for acetaminophen, DM/guaifenesin, throat lozenges 07/30/21 Pt reports fever (temp 101.3) and continued symptoms 08/01/21 Pt reports occasional cough but is improving 08/02/21 Pt reports dry intermittent cough, loss of appetite, muscle pain 08/03/21 Pt reports he has recovered and only residual symptom is an intermittent dry cough
Erythematous, indurated area left thigh with few papules that extended internal and anterior aspect of thigh to knee area.  Mom noticed after picked patient up from nursery yesterday.  No fever, N/V/O reported.  Normal activity.  Treated with Benadryl last night with decrease erytheyma and induration in this AM (05/08/2003).
Information has been received from a licensed practical nurse concerning a 22 year old female, who 25-SEP-2008, was vaccinated with the second dose of GARDASIL, IM. Concomitant therapy included "birth control". "About a week post vaccination", the patient experienced swelling at the injection site, and two itchy hive like bumps on her opposite-side arm and leg. Physician reported that he recommended diphenhydramine HCL (BENADRYL) to treat the symptoms. No lot number was reported. No further information was provided. Additional information has been requested.